Press & Events

The L V Prasad Eye Institute (LVPEI), Hyderabad has been granted an Australian patent for a novel cell therapy that can be used to repair damaged corneas from a variety of corneal diseases. This unique ‘cell composition’ based therapy marks a significant milestone in the field of ophthalmology and cell-based therapies. 

The patent is granted for the advanced cell compositions comprising limbal epithelial and stromal cells for treating and preventing corneal diseases, along with their production methods and therapeutic applications.  The therapy has previously been granted a patent by the Patent Office, Government of India, for a period of 20 years in accordance with the provisions of the Patents Act, 1970. Government of India approved clinical trials are also under way. It will need more validation before it is available for patient use.  

The patent was granted to two inventors from LVPEI, Drs Sayan Basu and Vivek Singh. Dr Basu is a ...

Most people associate cancer with the lungs, breast, or skin, but few realize that cancer can also affect the eyes. While eye cancer is rare, it can be life-threatening and lead to permanent loss of vision or even eye enucleation (removal of eye), if not detected early. Unfortunately, lack of awareness leads to many cases being diagnosed at an advanced stage, when treatment options become limited.

The Growing Burden of Eye Cancer in India
India carries one of the highest burdens of eye cancer worldwide, particularly childhood eye cancers. Retinoblastoma, a life-threatening eye cancer in children, is more common in India than in  other countries. The Asia-Pacific region bears the highest number of retinoblastoma cases globally, with India having the largest number of reported cases. 

In adults, ocular surface squamous neoplasia (OSSN) and sebaceous gland carcinoma are among the most common eye cancers. OSSN is the leading conjunctival malignancy, while ...

[Bhubaneswar, February 19, 2025]: The Manorama Choudhury Nayan Jyoti Vision-Aid CVI Resource Centre, a pioneering effort to alleviate the challenges faced by children with CVI and their families was made possible with the support of Vision-Aid USA. The centre was inaugurated on February 19, 2025 by  Mrs. Manorama Choudhury the donor of the centre, in the presence of Vision-Aid founders Mr. Ramakrishna (Ram) Raju and Mrs. Revathy Ramakrishna, Mr Sanyasi Kumar Behera, Deputy Secretary of Social Security & Empowerment of Persons with Disability Department (SSEPD), other dignitaries from within LVPEI and beyond.  

CVI constitutes a brain-based visual impairment where the eyes may function normally, but the brain's ability to interpret and comprehend visual information is impaired. Approximately 30–40% of children with visual impairment have CVI, which ranks among the leading causes of paediatric visual impairment worldwi...